Vanadium as potential therapeutic agent for COVID-19: A focus on its antiviral, antiinflamatory, and antihyperglycemic effects

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations

Abstract

An increasing evidence suggests that vanadium compounds are novel potential drugs in the treatment of diabetes, atherosclerosis, and cancer. Vanadium has also demonstrated activities against RNA viruses and is a promising candidate for treating acute respiratory diseases. The antidiabetic, antihypertensive, lipid-lowering, cardioprotective, antineoplastic, antiviral, and other potential effects of vanadium are summarized here. Given the beneficial antihyperglycemic and antiinflammatory effects as well as the potential mechanistic link between the COVID-19 and diabetes, vanadium compounds could be considered as a complement to the prescribed treatment of COVID-19. Thus, further clinical trials are warranted to confirm these favorable effects of vanadium treatment in COVID-19 patients, which appear not to be studied yet.

Original languageBritish English
Article number126887
JournalJournal of Trace Elements in Medicine and Biology
Volume69
DOIs
StatePublished - Jan 2022

Keywords

  • COVID-19
  • Diabetes mellitus
  • Hyperglycemia
  • Inflammation
  • Insulin sensitivity
  • SARS-CoV-2 coronavirus
  • Vanadium

Fingerprint

Dive into the research topics of 'Vanadium as potential therapeutic agent for COVID-19: A focus on its antiviral, antiinflamatory, and antihyperglycemic effects'. Together they form a unique fingerprint.

Cite this